Total Payments
$5,333
2024 Payments
$675.25
Companies
34
Transactions
183
Medicare Patients
1,822
Medicare Billing
$300,888
Payment Breakdown by Category
Food & Beverage$4,177 (78.3%)
Consulting$800.00 (15.0%)
Travel$304.49 (5.7%)
Education$51.16 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,177 | 178 | 78.3% |
| Consulting Fee | $800.00 | 1 | 15.0% |
| Travel and Lodging | $304.49 | 1 | 5.7% |
| Education | $51.16 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $1,468 | 11 | $0 (2022) |
| ABBVIE INC. | $897.01 | 57 | $0 (2024) |
| Abbott Laboratories | $635.27 | 45 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $242.39 | 2 | $0 (2024) |
| Relievant Medsystems, Inc. | $208.74 | 3 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $197.47 | 5 | $0 (2021) |
| Novo Nordisk Inc | $151.72 | 3 | $0 (2024) |
| Nalu Medical, Inc. | $140.32 | 1 | $0 (2021) |
| Lilly USA, LLC | $117.98 | 4 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $116.03 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $675.25 | 23 | ABBVIE INC. ($134.48) |
| 2023 | $720.69 | 27 | ABBVIE INC. ($225.11) |
| 2022 | $2,437 | 65 | Biohaven Pharmaceutical Holding Company Ltd. ($1,468) |
| 2021 | $1,500 | 68 | Abbott Laboratories ($375.43) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $50.39 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: VIROLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Opioid Analgesic | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: PAIN | ||||||
| 06/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: VACCINE | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $70.73 | General |
| Category: Diabetes | ||||||
| 03/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $96.48 | General |
| Category: Immunology | ||||||
| 03/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: PAIN | ||||||
| 02/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Education | In-kind items and services | $27.00 | General |
| Category: Drug Infusion Systems | ||||||
| 01/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: PAIN | ||||||
| 12/18/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 280 | 817 | $223,481 | $43,163 |
| 2022 | 8 | 408 | 967 | $341,094 | $68,162 |
| 2021 | 9 | 710 | 1,582 | $581,864 | $129,616 |
| 2020 | 7 | 424 | 1,176 | $387,959 | $59,946 |
Total Patients
1,822
Total Services
4,542
Medicare Billing
$300,888
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 557 | $211,382 | $41,110 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 34 | $9,083 | $1,581 | 17.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 84 | 108 | $1,836 | $372.36 | 20.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 118 | $1,180 | $99.85 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 608 | $230,736 | $44,796 | 19.4% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 32 | 39 | $29,250 | $8,627 | 29.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 29 | 32 | $19,200 | $6,163 | 32.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 55 | 69 | $41,400 | $4,167 | 10.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 49 | $13,090 | $2,817 | 21.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 30 | $5,598 | $1,308 | 23.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 48 | 60 | $1,020 | $208.22 | 20.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 16 | 80 | $800.00 | $75.22 | 9.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 260 | 710 | $245,830 | $53,789 | 21.9% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 108 | 202 | $151,500 | $49,878 | 32.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 117 | 243 | $145,800 | $15,100 | 10.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 36 | 41 | $24,600 | $8,148 | 33.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 17 | 22 | $4,202 | $1,058 | 25.2% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 136 | 289 | $4,913 | $1,010 | 20.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 15 | $4,365 | $517.31 | 11.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 14 | 18 | $360.00 | $81.14 | 22.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 11 | 42 | $294.00 | $35.20 | 12.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 232 | 722 | $309,738 | $47,141 | 15.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 26 | 46 | $19,734 | $3,394 | 17.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $18,508 | $3,056 | 16.5% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2020 | 34 | 47 | $17,484 | $2,650 | 15.2% |
About Daryl Potter, FNP-C
Daryl Potter, FNP-C is a Family healthcare provider based in Gatesville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2014. The National Provider Identifier (NPI) number assigned to this provider is 1124442199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daryl Potter, FNP-C has received a total of $5,333 in payments from pharmaceutical and medical device companies, with $675.25 received in 2024. These payments were reported across 183 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,177).
As a Medicare-enrolled provider, Potter has provided services to 1,822 Medicare beneficiaries, totaling 4,542 services with total Medicare billing of $300,888. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Gatesville, TX
- Active Since 02/12/2014
- Last Updated 11/25/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1124442199
Products in Payments
- NURTEC ODT (Drug) $1,658
- UBRELVY (Drug) $538.75
- Proclaim IPG (Device) $296.65
- QULIPTA (Drug) $271.32
- Intracept (Device) $208.74
- PROCLAIM (Device) $147.35
- Nalu Neurostimulation System (Device) $140.32
- FARXIGA (Drug) $123.76
- Wegovy (Drug) $123.76
- TEZSPIRE (Biological) $118.63
- Seglentis (Drug) $116.03
- OCTRODE (Device) $112.49
- Aimovig (Biological) $111.78
- DUPIXENT (Biological) $96.48
- Superion (Device) $94.69
- QUVIVIQ (Drug) $89.32
- MOUNJARO (Drug) $87.38
- Dexcom G6 Transmitter (Medical Supply) $80.39
- Octrode SCS Leads (Device) $78.78
- VRAYLAR (Drug) $75.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Gatesville
Dawn Marie Pessa, Msn, Fnp-Bc, MSN, FNP-BC
Family — Payments: $2,591
Family $2,591
Rhonda Mangum, Fnp-Bc, FNP-BC
Family — Payments: $1,895
Family $1,895
Alecia Eads, Fnp, FNP
Family — Payments: $1,333
Family $1,333
Nicole Batcheller, Fnp-C, FNP-C
Family — Payments: $741.48
Family $741.48
Anthony Podbielski, Fnp-C, FNP-C
Family — Payments: $629.75
Family $629.75
Lesa Rodriguez, Fnp, FNP
Family — Payments: $344.10
Family $344.10